DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Deodhar A, Gensler LS, Kay J. et al.
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.
Arthritis Rheumatol 2019;
DOI: 10.1002/art.40866..
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.